Recruiting studies: Opioid Craving

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

tDCS to Decrease Opioid Relapse (UH3)
NA · 1 location(s) · Butler Hospital · NCT06432465 Sparrow Link Neuromodulation Device for Opioid Withdrawal Management in Hospitalized Adults With Opioid Use Disorder
NA · 1 location(s) · Payel Roy · NCT07079826 Evaluating Buspirone to Treat Opioid Withdrawal
Phase 2 · 1 location(s) · University of Maryland, Baltimore · NCT05511909 Assessing a Clinically-meaningful Opioid Withdrawal Phenotype
Phase 2 · 1 location(s) · University of Maryland, Baltimore · NCT05027919 Systematic Examination of Health Inequalities: Documentation, Patterns, and Determinants
Phase N/A · 5 location(s) · University of Thessaly · NCT07558187 Ketamine for Opioid Use Disorder
Phase 2 · 1 location(s) · University of Maryland, Baltimore · NCT06943859 Effect of Olanzapine on Opioid Craving and Misuse Among Patients Receiving Opioids for Cancer-related Pain: A Pilot Doub
Phase 3 · 1 location(s) · M.D. Anderson Cancer Center · NCT06200181 Sensing Physiological Symptoms of Opioid Withdrawal and Cravings in Patients With Opioid Use Disorder
Phase N/A · 2 location(s) · Spark Biomedical, Inc. · NCT06487533 Craving & Decision-Making
NA · 1 location(s) · Rutgers, The State University of New Jersey · NCT06440577

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.